Skip to content

Clinical trials

Phase 1/2 Lymphoma, Non-Hodgkin trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 1/2 Country / region: South Korea Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20092
20121
20153
20171
20181
20195
20212
20221
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting7
Active, not recruiting3
Terminated3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Accenture1
Asan Medical Center1
BeOne Medicines1
Bristol-Myers Squibb1
Celgene1
Cellestia Biotech AG1
GC Cell Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin23
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma, Follicular6
Lymphoma, Large B-Cell, Diffuse6
Hodgkin Disease4
Lymphoma4
Lymphoma, B-Cell4
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, Mantle-Cell4
Multiple Myeloma3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.